Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors

摘要

Provided herein are methods for treating or preventing pulmonary fibrosis in subjects suffering from diffuse parenchymal lung diseases using selective active-site mTOR inhibitors.